Neurogene Inc.

NASDAQ: NGNE
Share price (3/28/25): $14.52
Market cap (3/28/25): $217 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Late quarterly filing notification for Q3 2024

ended 06/30/24 Q2

ended 03/31/24 Q1

Prospectuses and Registrations Filter

Shelf registration

Updated info for already-effective prospectus

Registration of securities for employees

Prospectus supplement

Initial registration of new securities

Ownership Filter

Cvijic Christine Mikail

Cvijic Christine Mikail

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates

Investor Presentation

Material Disclosure

Reports Third Quarter 2024 Financial Results and Highlights Recent Updates

Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

SEC STAFF LETTER